These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1635 related items for PubMed ID: 17161060

  • 1. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 2. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 3. Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.
    Palazzuoli A, Silverberg DS, Iovine F, Calabrò A, Campagna MS, Gallotta M, Nuti R.
    Am Heart J; 2007 Oct 23; 154(4):645.e9-15. PubMed ID: 17892986
    [Abstract] [Full Text] [Related]

  • 4. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A, Silverberg DS, Calabrò A, Spinelli T, Quatrini I, Campagna MS, Franci B, Nuti R.
    J Cardiovasc Pharmacol; 2009 Jun 23; 53(6):462-7. PubMed ID: 19455052
    [Abstract] [Full Text] [Related]

  • 5. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS, Wexler D, Iaina A, Schwartz D.
    Semin Nephrol; 2006 Jul 23; 26(4):296-306. PubMed ID: 16949468
    [Abstract] [Full Text] [Related]

  • 6. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
    Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM.
    J Am Coll Cardiol; 2006 Sep 19; 48(6):1225-7. PubMed ID: 16979010
    [Abstract] [Full Text] [Related]

  • 7. Are hematinic deficiencies the cause of anemia in chronic heart failure?
    Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL.
    Am Heart J; 2004 May 19; 147(5):924-30. PubMed ID: 15131553
    [Abstract] [Full Text] [Related]

  • 8. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
    Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R, Ryan E, Wasserman SM, Baker N, Rosser D, Rosen SD, Poole-Wilson PA, Banasiak W, Coats AJ, McDonald K.
    J Am Coll Cardiol; 2007 Feb 20; 49(7):753-62. PubMed ID: 17306703
    [Abstract] [Full Text] [Related]

  • 9. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS, Wexler D, Iaina A.
    J Nephrol; 2004 Feb 20; 17(6):749-61. PubMed ID: 15593047
    [Abstract] [Full Text] [Related]

  • 10. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar 20; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 11. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J, Ruiz S, Cladellas M, Rizzo M, Torres A, Bruguera J.
    J Card Fail; 2009 Nov 20; 15(9):727-35. PubMed ID: 19879457
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P, Voors AA, Lipsic E, Smilde TD, van Gilst WH, van Veldhuisen DJ.
    J Am Coll Cardiol; 2004 Jul 07; 44(1):63-7. PubMed ID: 15234408
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P.
    J Am Coll Cardiol; 2008 Jan 15; 51(2):103-12. PubMed ID: 18191732
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure.
    Wexler D, Silverberg D, Sheps D, Blum M, Keren G, Iaina A, Schwartz D.
    Int J Cardiol; 2004 Jul 15; 96(1):79-87. PubMed ID: 15203265
    [Abstract] [Full Text] [Related]

  • 15. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations.
    Silverberg DS, Wexler D, Blum M, Iaina A.
    Clin Nephrol; 2003 Jul 15; 60 Suppl 1():S93-102. PubMed ID: 12940539
    [Abstract] [Full Text] [Related]

  • 16. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 15; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 17. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J, Patal S, Wexler D, Abashidze A, Shmilovich H, Barak T, Sheps D, Keren G.
    Arch Intern Med; 2005 Jun 13; 165(11):1304-9. PubMed ID: 15956012
    [Abstract] [Full Text] [Related]

  • 18. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, Giammanco M, Sarullo FM, Licata G.
    J Am Coll Cardiol; 2005 Jun 21; 45(12):1997-2003. PubMed ID: 15963399
    [Abstract] [Full Text] [Related]

  • 19. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI, Zueva EB, Silverberg DS, Shaked M.
    J Nephrol; 2008 Jun 21; 21(2):236-42. PubMed ID: 18446719
    [Abstract] [Full Text] [Related]

  • 20. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
    Silverberg DS, Wexler D, Blum M, Schwartz D, Keren G, Sheps D, Iaina A.
    Isr Med Assoc J; 2003 May 21; 5(5):337-9. PubMed ID: 12811950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.